Rapid response to cemiplimab for advanced cutaneous squamous cell carcinoma.

ABSTRACT:

SUBMITTER: Zargham H 

PROVIDER: S-EPMC9305312 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature